Submitted:
04 July 2026
Posted:
06 July 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| DR | Diabetic retinopathy |
| DM | Diabetes mellitus |
| VTDR | Vision-threatening diabetic retinopathy |
| AI | Artificial intelligence |
| GR | Gradability rates |
| MA | Medical assistant |
References
- CDC. Diabetes. 2024 [cited 2025 June 11]. National Diabetes Statistics Report. Available from: https://www.cdc.gov/diabetes/php/data-research/index.html.
- Lundeen EA, Burke-Conte Z, Rein DB, Wittenborn JS, Saaddine J, Lee AY, et al. Prevalence of Diabetic Retinopathy in the US in 2021. JAMA Ophthalmol. 2023 Aug 1;141(8):747.
- Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology. 2021 Nov;128(11):1580–91.
- Tozer K, Woodward MA, Newman-Casey PA. Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs. J Endocrinol Diabetes. 2015;2(4).
- 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2025 | Diabetes Care | American Diabetes Association [Internet]. [cited 2025 July 29]. Available from: https://diabetesjournals.org/care/article/48/Supplement_1/S252/157552/12-Retinopathy-Neuropathy-and-Foot-Care-Standards.
- Bellemo V, Lim G, Rim TH, Tan GSW, Cheung CY, Sadda S, et al. Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application. Curr Diab Rep. 2019 July 31;19(9):72.
- Grzybowski A, Jin K, Zhou J, Pan X, Wang M, Ye J, et al. Retina Fundus Photograph-Based Artificial Intelligence Algorithms in Medicine: A Systematic Review. Ophthalmol Ther. 2024 Aug 1;13(8):2125–49.
- Grzybowski A, Brona P, Lim G, Ruamviboonsuk P, Tan GSW, Abramoff M, et al. Artificial intelligence for diabetic retinopathy screening: a review. Eye. 2020 Mar;34(3):451–60.
- Nanegrungsunk O, Ruamviboonsuk P, Grzybowski A. Prospective studies on artificial intelligence (AI)-based diabetic retinopathy screening. Ann Transl Med. 2022 Dec;10(24):1297–1297.
- EyeArt [Internet]. Eyenuk, Inc. ~ Artificial Intelligence Eye Screening. 2020 [cited 2025 June 23]. Available from: https://www.eyenuk.com/us-en/products/eyeart/.
- Grzybowski A, Rao DP, Brona P, Negiloni K, Krzywicki T, Savoy FM. Diagnostic Accuracy of Automated Diabetic Retinopathy Image Assessment Softwares: IDx-DR and Medios Artificial Intelligence. Ophthalmic Res. 2023 Sept 27;66(1):1286–92.
- AEYE Diagnostic Screening | AEYE Health [Internet]. [cited 2025 July 1]. Available from: https://www.aeyehealth.com/aeye-diagnostic-screening.
- New FDA Clearance Makes Eyenuk the First Company with Multiple Cameras for Autonomous AI Detection of Diabetic Retinopathy [Internet]. Eyenuk, Inc. ~ Artificial Intelligence Eye Screening. 2023 [cited 2025 June 23]. Available from: https://www.eyenuk.com/us-en/articles/news/eyenuk-fda-multiple-cameras.
- Kanagasingam Y, Xiao D, Vignarajan J, Preetham A, Tay-Kearney ML, Mehrotra A. Evaluation of Artificial Intelligence–Based Grading of Diabetic Retinopathy in Primary Care. JAMA Netw Open. 2018 Sept 28;1(5):e182665.
- Wintergerst MWM, Bejan V, Hartmann V, Schnorrenberg M, Bleckwenn M, Weckbecker K, et al. Telemedical Diabetic Retinopathy Screening in a Primary Care Setting: Quality of Retinal Photographs and Accuracy of Automated Image Analysis. Ophthalmic Epidemiol. 2022 June 1;29(3):286–95.
- Yang MC, Lin KY. Drug-induced Acute Angle-closure Glaucoma: A Review. J Curr Glaucoma Pract. 2019;13(3):104–9.
- Rajalakshmi R, Prathiba V, Arulmalar S, Usha M. Review of retinal cameras for global coverage of diabetic retinopathy screening. Eye. 2021 Jan;35(1):162–72.
- Vujosevic S, Aldington SJ, Silva P, Hernández C, Scanlon P, Peto T, et al. Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol. 2020 Apr;8(4):337–47.
- Murgatroyd H, Ellingford A, Cox A, Binnie M, Ellis JD, MacEwen CJ, et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol. 2004 July 1;88(7):920.
- Deb-Joardar N, Germain N, Thuret G, Manoli P, Garcin AF, Millot L, et al. Screening for Diabetic Retinopathy by Ophthalmologists and Endocrinologists With Pupillary Dilation and a Nonmydriatic Digital Camera. Am J Ophthalmol. 2005 Nov;140(5):814-821.e2.
- Li P, Paulus Y, Davila J, Gosbee J, Margolis T, Fletcher D, et al. Usability testing of a smartphone-based retinal camera among first-time users in the primary care setting. BMJ Innov. 2019 Oct;5(4):120–6.
- Maberley D, Morris A, Hay D, Chang A, Hall L, Mandava N. A comparison of digital retinal image quality among photographers with different levels of training using a non-mydriatic fundus camera. Ophthalmic Epidemiol. 20040701;11(3):191–7.


| MA | Photographs Taken (#) | Photographs Gradable (#) | Photographs Gradable (%) | |
|---|---|---|---|---|
| 1 | 97 | 54 | 55.6 | |
| 2 | 104 | 76 | 73.0 | |
| 3 | 275 | 154 | 56.0 | |
| 4 | 12 | 8 | 66.6 | |
| 5 | 12 | 7 | 58.3 | |
| 6 | 20 | 4 | 20.0 | |
| 7 | 22 | 14 | 63.6 | |
| 8 | 28 | 5 | 17.8 | |
| 9 | 31 | 19 | 61.2 | |
| 10 | 39 | 31 | 79.4 | |
| 11 | 42 | 16 | 38.0 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).